KLK6 has been implicated in EMT in breast cancer (Pampalakis et al., 2009), in gastric cancer by reducing the expression of E‐cadherin at the transcriptional level (Kim et al., 2012), and in colon cancer (Kim et al., 2011). The gene discussed is KLK6; the disease is breast cancer.